Section Arrow
Quote
POAS.NYSE-M
- Phaos Technology (Cayman) Holdings Ltd.
Quotes are at least 15-min delayed:2026/10/01 19:15 EDT
After Hours
Last
 0.18
+0.002 (+1.12%)
Bid
0.18
Ask
0.1868
High 0.1868 
Low 0.176 
Volume 49.39K 
Regular Hours (Closed)
Last
 0.178
+0.008 (+4.71%)
Day High 
0.1868 
Prev. Close
0.17 
1-M High
0.18 
Volume 
905.67K 
Bid
0.18
Ask
0.1868
Day Low
0.1602 
Open
0.161 
1-M Low
0.15 
Market Cap 
2.80M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.17 
20-SMA 0.17 
50-SMA 0.18 
52-W High 7.395 
52-W Low 0.1466 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.49/--
Enterprise Value
2.93M
Balance Sheet
Book Value Per Share
0.25
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
132.08K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NXLNexalin Technology Inc.7.55+3.27+76.40%-- 
After Hours 6.6 -0.95 -12.58%
PACBPacific Biosciences of California2.51+0.14+5.91%-- 
After Hours 2.49 -0.02 -0.80%
QSIQuantum-Si1.43+0.36+33.64%-- 
After Hours 1.385 -0.045 -3.15%
MDTMedtronic plc86.44+0.15+0.17%21.25PE
After Hours 86.64 +0.2 +0.23%
BSXBoston Scientific Corp43.23-0.42-0.96%17.67PE
After Hours 43.2062 -0.0238 -0.06%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers high tech microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.